1. Home
  2. CTSO vs AP Comparison

CTSO vs AP Comparison

Compare CTSO & AP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.67

Market Cap

45.9M

Sector

Health Care

ML Signal

HOLD

Logo Ampco-Pittsburgh Corporation

AP

Ampco-Pittsburgh Corporation

HOLD

Current Price

$3.69

Market Cap

44.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTSO
AP
Founded
1997
1929
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Fluid Controls
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
45.9M
44.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CTSO
AP
Price
$0.67
$3.69
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$5.38
N/A
AVG Volume (30 Days)
114.9K
200.2K
Earning Date
11-13-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$36,979,520.00
$426,314,000.00
Revenue This Year
$9.51
N/A
Revenue Next Year
$24.40
N/A
P/E Ratio
N/A
N/A
Revenue Growth
23.89
0.20
52 Week Low
$0.60
$1.75
52 Week High
$1.61
$3.99

Technical Indicators

Market Signals
Indicator
CTSO
AP
Relative Strength Index (RSI) 43.59 77.71
Support Level $0.66 $3.25
Resistance Level $0.76 $3.59
Average True Range (ATR) 0.07 0.31
MACD -0.00 0.10
Stochastic Oscillator 24.33 91.55

Price Performance

Historical Comparison
CTSO
AP

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

About AP Ampco-Pittsburgh Corporation

Ampco-Pittsburgh Corp is manufacturing and selling engineered, specialty metal products and customized equipment. It operates in two business segments namely the Forged and Cast Engineered Products segment and the Air and Liquid Processing segment. The Forged and Cast Engineered Products segment produces forged hardened steel rolls, cast rolls, and open-die forged products. Forged hardened steel rolls are used in cold rolling mills by producers of steel, aluminum, and other metals whereas, the Air and Liquid Processing segment includes Aerofin, Buffalo Air Handling, and Buffalo Pumps. The company generates a majority of its revenue from the Forged and Cast Engineered Products segment. It has a business presence in the United States and other countries.

Share on Social Networks: